18 Jun 2008
Patients who suffer from depression are at greater risk of developing type 2 diabetes and vice versa, researchers suggest.
A new study led by physicians at John Hopkins Hospital found that patients with elevated symptoms of depression were 42 per cent more likely to develop diabetes than those who did not present signs of the illness.
The researchers highlighted a correlation between the severity of depression in patients and the level of diabetes risk.
According to the study, when other factors such as - weight, lack of exercise and smoking - were taken into account, the risk of developing diabetes was still 34 per cent higher for patients with depressive symptoms.
In addition, the findings revealed that patients treated for diabetes were around 54 per cent more at risk of developing elevated depressive symptoms than those without diabetes.
Writing in the Journal of the American Medical Association, diabetes expert and lead researcher Dr Sherita Hill Golden said: "Having both diabetes and depression can make it difficult for patients to get the good clinical outcomes that we like to see for each of these conditions.
"To make sure that patients with diabetes and depression receive the best care, we wanted to get to the bottom of the connection between these two conditions. It's important that doctors be attuned to look for both conditions in patients at risk for either diabetes or depression."
Looking forward Dr Golden suggests the development of interventions for both treatments rather than one or the other individually may be beneficial.
Login and visit the Diabetes Knowledge CentreRegister now to access our FREE educational library
Print Article 
Bookmark
- Porridge could limit type-2 diabetes side effects 09/01/09
- Men with type-2 diabetes at greater risk of cardiovascular death 06/01/09
- Decline in mental processing affects diabetes patients, study reveals 05/01/09
- Leptin study could lead to new diabetes treatment 23/12/08
- Symptomless virus linked with type 1 diabetes 19/12/08
Disease Knowledge Centres feed
-
PRANDIN Tablets - 49.44%
... in patients with Type 2 diabetes (Non Insulin-Dependent Diabetes Mellitus (NIDDM)) whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. Repaglinide is also indicated in combination with metformin in Type 2 diabetes patients who are not ... -
DDAVP - 49.42%
... and treatment of vasopressin-sensitive cranial diabetes insipidus; establishing renal concentration capacity. DDAVP Tablets: Treatment of vasopressin-sensitive cranial diabetes insipidus; treatment of post-hypophysectomy polyuria/ polydipsia. DDAVP/Desmopressin Injection: Cranial diabetes insipidus ... -
JANUVIA Film-Coated Tablets - 47.95%
JANUVIA is indicated in patients with type 2 diabetes mellitus to improve glycaemic control in combination with metformin when diet and exercise, plus metformin do not provide adequate glycaemic control. For patients with type 2 diabetes mellitus in whom use of a PPAR? agonist (i.e. a ... -
EXUBERA - 47.95%
... for the treatment of adult patients with type 2 diabetes mellitus not adequately controlled with oral antidiabetic agents and requiring insulin therapy. EXUBERA is also indicated for the treatment of adult patients with type 1 diabetes mellitus, in addition to long or intermediate acting ... -
NOCUTIL - 47.95%
Treatment of idiopathic central diabetes insipidus, or diabetes insipidus occurring after hypophysectomy, cranial trauma, or surgery in the pituitary region ... -
GLUCOPHAGE - 47.95%
Non-insulin dependent (type II) diabetes either alone or with sulphonylureas. Adjuvant therapy in insulin-dependent diabetes, particularly in the obese ...
Printed on 09/01/2009 10:19 PM
